Pharmaceutical Business review

China Ruitai sees fall in Q1 sales

China Ruitai’s net income was $735,893, or $0.03 per diluted share, compared to net income of $1.94m, or $0.07 per diluted share, for the comparable period last year.

Income from operations was $1.55m, compared to $2.67m for the same period in 2010.

Gross profit decreased by 15% year-over-year to $2.8m.

China Ruitai chairman Dianmin Ma said along with others in the industry, their outlook for the balance of the year is positive despite some setbacks in the first quarter.

Exit mobile version